1. Home
  2. XELB vs VYNE Comparison

XELB vs VYNE Comparison

Compare XELB & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.05

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
VYNE
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
XELB
VYNE
Price
$1.05
$0.38
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$3.00
N/A
AVG Volume (30 Days)
48.2K
846.3K
Earning Date
11-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,980,000.00
$524,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
$16.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.29
52 Week Low
$0.74
$0.28
52 Week High
$7.40
$4.30

Technical Indicators

Market Signals
Indicator
XELB
VYNE
Relative Strength Index (RSI) 51.12 53.25
Support Level $0.91 $0.37
Resistance Level $1.02 $0.39
Average True Range (ATR) 0.08 0.03
MACD 0.04 0.00
Stochastic Oscillator 84.76 60.00

Price Performance

Historical Comparison
XELB
VYNE

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: